U.S. Markets closed

IGM Biosciences, Inc. (IGMS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
74.82+4.30 (+6.10%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3133.00
52 Week Low 342.00
50-Day Moving Average 373.25
200-Day Moving Average 376.74

Share Statistics

Avg Vol (3 month) 3134.56k
Avg Vol (10 day) 3123.3k
Shares Outstanding 525.59M
Implied Shares Outstanding 6N/A
Float 7.98M
% Held by Insiders 143.15%
% Held by Institutions 165.31%
Shares Short (Jul 29, 2021) 42.95M
Short Ratio (Jul 29, 2021) 423.02
Short % of Float (Jul 29, 2021) 436.77%
Short % of Shares Outstanding (Jul 29, 2021) 49.20%
Shares Short (prior month Jun 29, 2021) 42.95M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-24.96%
Return on Equity (ttm)-43.54%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-39.16M
EBITDA -113.1M
Net Income Avi to Common (ttm)-115.25M
Diluted EPS (ttm)-26.20
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)281.44M
Total Cash Per Share (mrq)8.78
Total Debt (mrq)12.64M
Total Debt/Equity (mrq)3.92
Current Ratio (mrq)15.22
Book Value Per Share (mrq)8.35

Cash Flow Statement

Operating Cash Flow (ttm)-92.45M
Levered Free Cash Flow (ttm)-74.58M